A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2002
12/12/2002	WO2002089850A8 Long acting antimicrobic preparation
12/12/2002	WO2002089788A3 Pharmaceutical compositions comprising a hmg-coa reductase inhibitor
12/12/2002	WO2002087600A8 Use of phyllanthus constituents for treating or preventing infections caused by hepatit
12/12/2002	WO2002083891A3 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
12/12/2002	WO2002080890A3 A jasmonate pharmaceutical composition for treatment of cancer
12/12/2002	WO2002077000A3 Macrocyclic oligosaccharide derivatives which form manoscale assemblies
12/12/2002	WO2002076432A3 Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
12/12/2002	WO2002072052A3 Skin care products with improved skin and material softness
12/12/2002	WO2002068015A9 Modular infusion device and method
12/12/2002	WO2002067770A3 Implantable device using ultra-nanocrystalline diamond
12/12/2002	WO2002064543A3 Novel succinate salt of o-desmethyl-venlafaxine
12/12/2002	WO2002064093A3 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
12/12/2002	WO2002064089A3 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides
12/12/2002	WO2002062843A3 Modified erythropoietin (epo) with reduced immunogenicity
12/12/2002	WO2002058586A3 Systemic formulations containing beta-carotene and derivatives thereof
12/12/2002	WO2002056852A9 Cosmetics
12/12/2002	WO2002045686A3 Pharmaceutical paste comprising an acid-labile active ingredient
12/12/2002	WO2002036163A3 Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses
12/12/2002	WO2002028366A3 Devices and methods for management of inflammation
12/12/2002	WO2002011709A3 Pharmaceutical, effervescent formulation containing ramipril
12/12/2002	WO2002009729A3 Treatment of hyperproliferative skin disorders and diseases
12/12/2002	WO2002002077A3 Liposomal antineoplastic drugs and uses thereof
12/12/2002	WO2002000246A8 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency
12/12/2002	US20020188282 Implantable drug delivery device
12/12/2002	US20020188281 Stabilized bioactive preparations and method of use
12/12/2002	US20020188248 Needleless syringe using super sonic gas flow for particle delivery
12/12/2002	US20020188170 Prevention of myocardial infarction induced ventricular expansion and remodeling
12/12/2002	US20020188165 Permanent magnet keeper-shield assembly
12/12/2002	US20020188134 Pharmaceutical compositions
12/12/2002	US20020188101 Conjugated peptide nucleic acids having enhanced cellular uptake
12/12/2002	US20020188100 Boron compound for use in the treatment of stroke, heart defects, inflammation, autoimmune and cancer disease
12/12/2002	US20020188052 Barium ferrite filler; magnetic tapes
12/12/2002	US20020188028 Anti-infective compositions, methods and systems for treating disordered tissue
12/12/2002	US20020188023 Compound
12/12/2002	US20020188019 Use of hydroxyflavanones for masking bitter taste
12/12/2002	US20020188002 Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence
12/12/2002	US20020187936 Methods of treating liver disease and liver damage with growth hormone and foxM1B
12/12/2002	US20020187933 Cardiovascular disorders; regeneration of heart tissue
12/12/2002	US20020187536 Enzymatic polypeptide for use in treating lactose intolerance
12/12/2002	US20020187387 Nano-ionic products and devices
12/12/2002	US20020187260 Inert and biocompatible conformal coating to mitigate adverse responses following device implantation in a patient, to contain and seal a drug or other material within the device, and/or to insulate the electrical connections to the device.
12/12/2002	US20020187248 Quantity of the dispensed pharmaceutical(s) are controllably dispensed to customize each pharmaceutical dose to suit the needs of a particular user; coupled by an external telecommunication network
12/12/2002	US20020187208 Plant extract that inhibits the release of Tumor Necrosis Factor alpha (TNF-alpha)
12/12/2002	US20020187199 Unimolecular polymeric micelles with an ionizable inner core
12/12/2002	US20020187197 Templating of solid particles by polymer multilayers
12/12/2002	US20020187196 Capsules capsules actic-co-glycolic copolymer to which a citric ester plasticizer has been incorporated and which contain a peptide drug within them.
12/12/2002	US20020187195 Contains a polymer, such as polyethylene glycol, and an acid salt of a compound having 3 or more carbon atoms, salt such as sodium propionate. The solvent may optionally contain a cosolvent, such as dimethyl isosorbide.
12/12/2002	US20020187193 E.g., 7-(3-amino-2,3,4,5,6,7-hexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6 -fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid; treatment of ocular and periocular infections.
12/12/2002	US20020187192 Pharmaceutical composition which reduces or eliminates drug abuse potential
12/12/2002	US20020187190 Polymer film compositions for capsules
12/12/2002	US20020187189 Proliposomal drug delivery system
12/12/2002	US20020187188 Rapid-melt compositions methods of making same and methods of using same
12/12/2002	US20020187187 Fast disintegrating meloxicam tablet
12/12/2002	US20020187186 Pharmaceutical tablets
12/12/2002	US20020187185 Gelatin substitute
12/12/2002	US20020187184 Method of treating restenosis using bisphosphonate nanoparticles
12/12/2002	US20020187183 Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system
12/12/2002	US20020187181 System for delivering cosmetics and pharmaceuticals
12/12/2002	US20020187179 Non-steroidal anabolic compositions and associated methods
12/12/2002	US20020187172 Polymeric material associated with colloidal metal particles, especially gold, suitable for injection or implantation.
12/12/2002	US20020187171 Composition for solubilizing salicylic acid
12/12/2002	US20020187169 Kavalactone compositions
12/12/2002	US20020187165 Composition for female sexual arousal
12/12/2002	US20020187149 Activity-inhibiting amount of a growth factor neutralising agent or agents specific against only fibrotic growth factors together with a pharmaceutically acceptible carrier.
12/12/2002	US20020187134 Prebiotic and probiotic compositions and methods for their use in gut-based therapies
12/12/2002	US20020187106 Methods for tobramycin inhalation
12/12/2002	US20020187105 Polymer combinations that result in stabilized aerosols for gene delivery to the lungs
12/12/2002	US20020187102 Novel compositions for use in embolizing blood vessels
12/12/2002	US20020185558 Method of milling pharmaceutical preparation
12/12/2002	DE10127526A1 Verfahren zur Herstellung und Auflösung von Nano- und Mikrokapseln Process for the preparation and resolution of nano- and micro-capsules
12/12/2002	DE10127232A1 Process for treating a particulate material with a coating medium comprises adding the material to a container in a continuous circulating movement, spraying with the coating medium, and drying with process air
12/12/2002	DE10126966A1 Films and coatings for storage or controlled release of active materials such as pharmaceuticals or a wide range of other actives are obtained by a sol-gel process with the active material in a carrier
12/12/2002	DE10125509A1 Homogenate production, especially for use in implants and/or microparticles, by homogenizing mixture of active agent, e.g. hormone, and polymer below the glass transition temperature in the absence of solvent
12/12/2002	DE10124952A1 Verfahren zur Herstellung von Nanodispersionen A process for preparing nanodispersions
12/12/2002	CA2449842A1 Zinc containing compositions for anti-viral use
12/12/2002	CA2449825A1 Use of an antioxidant for treating and/or preventing surface ocular disorders
12/12/2002	CA2449712A1 Method for reducing muscle fatigue through administration of adenosine triphosphate
12/12/2002	CA2449103A1 Topical compositions for veterinary uses
12/12/2002	CA2448861A1 Methods and formulations for enhancing the dissolution of a solid material in liquid
12/12/2002	CA2448858A1 Lipid-polymer-conjugates compositions
12/12/2002	CA2448856A1 Lipid-polymer-conjugates
12/12/2002	CA2448379A1 Calorically dense liquid oral supplement
12/12/2002	CA2447111A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds
12/12/2002	CA2445649A1 Method of tablet enrobing
12/11/2002	EP1264837A1 Conjugation-stabilized polypeptide compositions
12/11/2002	EP1264828A1 New inhibitor of urokinase
12/11/2002	EP1264604A2 Improvements in or relating to contrast agents
12/11/2002	EP1264602A2 Pharmaceutical composition comprising high tapped density fumed silica
12/11/2002	EP1264600A1 Immune enhancement compositions and use thereof
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1264595A1 Use of tocopherol derivatives for stabilizing nano-sized emulsion particles containing lecithin and their external application to the skin
12/11/2002	EP1264585A1 Steam evolving device
12/11/2002	EP1264548A2 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy
12/11/2002	EP1263922A1 Method for producing moulded bodies
12/11/2002	EP1263916A2 Liquid crystalline polymers
12/11/2002	EP1263884A1 Process for the preparation of micronised collagen, and its therapeutic applications
12/11/2002	EP1263849A1 Degradable cross-linking agents and cross-linked network polymers formed therewith
12/11/2002	EP1263802A1 Hydrogel biomedical articles
12/11/2002	EP1263801A1 Tissue bulking and coating compositions
12/11/2002	EP1263742A1 Oxazolidinone thioamides with piperazine amide substituents

1 ... 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 ... 2991